ACTIVE SUBSTANCE / INN

TALIMOGENE LAHERPAREPVEC

Brand name(s): Imlygic
EMA LISTED
AUTHORISED
Melanoma
ACTIVE SUBSTANCE
Talimogene Laherparepvec
REGULATORS
EMA
SPONSORS / MAH
Amgen Europe B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ImlygicAmgen Europe B.V.Authorised16/12/2015Melanoma

FULL INTELLIGENCE ON TALIMOGENE LAHERPAREPVEC

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →